Literature DB >> 19665677

Prothrombin time and partial thromboplastin time assay considerations.

Valerie L Ng1.   

Abstract

Prothrombin times and activated partial thromboplastin times have long been used as tests of overall ("global") clotting function. Laboratory coagulation testing issues should be at the forefront of the reader's consciousness whenever critically evaluating and extrapolating published study conclusions reliant on the results of these tests. Thus, this article reviews laboratory issues and known variables influencing prothrombin time and partial thromboplastin time results and international normalized ratio determinations.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19665677     DOI： 10.1016/j.cll.2009.05.002

Source DB:  PubMed          Journal:  Clin Lab Med        ISSN： 0272-2712            Impact factor:   1.935


  25 in total

Review 1.  A review on the role of L-carnitine in the management of tamoxifen side effects in treated women with breast cancer.

Authors:  Nahla E El-Ashmawy; Rania M Khalil
Journal:  Tumour Biol       Date:  2013-12-12

Review 2.  Novel oral anticoagulants: pharmacology, coagulation measures, and considerations for reversal.

Authors:  Larry R Jackson; Richard C Becker
Journal:  J Thromb Thrombolysis       Date:  2014-04       Impact factor: 2.300

3.  A novel μ-fluidic whole blood coagulation assay based on Rayleigh surface-acoustic waves as a point-of-care method to detect anticoagulants.

Authors:  Sascha Meyer Dos Santos; Anita Zorn; Zeno Guttenberg; Bettina Picard-Willems; Christina Kläffling; Karen Nelson; Ute Klinkhardt; Sebastian Harder
Journal:  Biomicrofluidics       Date:  2013-10-04       Impact factor: 2.800

4.  An International Normalized Ratio-Based Definition of Acute Traumatic Coagulopathy Is Associated With Mortality, Venous Thromboembolism, and Multiple Organ Failure After Injury.

Authors:  Ithan D Peltan; Lisa K Vande Vusse; Ronald V Maier; Timothy R Watkins
Journal:  Crit Care Med       Date:  2015-07       Impact factor: 7.598

5.  Effects of warfarin and L-carnitine on hemostatic function and oxidative stress in streptozotocin-induced diabetic rats.

Authors:  Ahmed A ElGendy; Amr M Abbas
Journal:  J Physiol Biochem       Date:  2014-03-27       Impact factor: 4.158

Review 6.  Coagulopathy in liver disease: Lack of an assessment tool.

Authors:  Annabel Blasi
Journal:  World J Gastroenterol       Date:  2015-09-21       Impact factor: 5.742

7.  Complications and 30-day Outcomes Associated With Venous Thromboembolism in the Pediatric Orthopaedic Surgical Population.

Authors:  Dustin Baker; Brandon Sherrod; Gerald McGwin; Brent Ponce; Shawn Gilbert
Journal:  J Am Acad Orthop Surg       Date:  2016-03       Impact factor: 3.020

8.  Prospective study of oral anticoagulants and risk of liver injury in patients with atrial fibrillation.

Authors:  Alvaro Alonso; Richard F MacLehose; Lin Y Chen; Lindsay Gs Bengtson; Alanna M Chamberlain; Faye L Norby; Pamela L Lutsey
Journal:  Heart       Date:  2017-01-05       Impact factor: 5.994

9.  A dyspnea patient with abnormal prolonged prothrombin time and activated partial thromboplstin time, but without bleeding symptoms.

Authors:  Zhi-de Hu; Bing Gu; An-Mei Deng
Journal:  J Thorac Dis       Date:  2012-04-01       Impact factor: 2.895

10.  Prothrombin time, activated partial thromboplastin time and platelet counts of type II diabetes mellitus: a comparative study.

Authors:  Yitayal Amogne Ambelu; Melashu Balew Shiferaw; Molla Abebe; Bamlaku Enawgaw
Journal:  J Diabetes Metab Disord       Date:  2018-08-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.